CannapharmaRx completes additional shipping in November

CALGARY, AB / ACCESSWIRE / November 5, 2024 / CannaPharmaRX, Inc. (OTC PINK:CPMD), a future leader in advanced, highly efficient cannabis production, is pleased to announce continued progress at its Cremona, Alberta facility, where cannabis cultivation remains on track according to the company’s annual plan. Following the resignation of CEO Dean Medwid in early September, the company has been able to continue its operations uninterrupted while fulfilling and delivering its orders.

Recent shipments to Israel
CannaPharmaRx has completed two shipments of its products to buyers in Israel. A third shipment of approximately 300 kg is currently in the final stages of preparation and is expected to be shipped shortly. The average price for the third shipment is estimated at CAD 2.10 per gram, with the final price based on batch quality and THC results.

In addition, an order has been received for a shipment of 250 kg of company product to Israel, which is expected to be delivered in the current quarter.
The company expects regular order and shipment growth by 2025, which will lead to significant revenue growth next year.

Following the successful launch of the company’s products in Israel, CannaPharmaRx is in preliminary discussions with companies in Europe and elsewhere internationally to increase distribution of our products and establish a global presence.

Contact:

Company: CannapharmaRx

Name: Constantine Nkafu

Website: https://cannapharmarx.com

Telephone: 403-637-0420

Mail: [email protected]

SOURCE: CannaPharmaRx

View the original press release on accesswire.com